CORRECTING and REPLACING Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Picard Medical Inc. (NASDAQ: PMI)

Core Viewpoint - Scott+Scott Attorneys at Law LLP has filed a securities class action lawsuit against Picard Medical Inc. due to allegations of a fraudulent stock promotion scheme that led to a significant drop in the company's stock price following an artificial inflation period [1] Group 1: Lawsuit Details - The lawsuit was filed in the U.S. District Court for the Northern District of California, asserting claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 [1] - The class period for the lawsuit is defined as September 2, 2025, to October 31, 2025, during which investors purchased Picard Medical Securities [1] - The lead plaintiff deadline for this action is set for April 13, 2026 [1] Group 2: Allegations Against Defendants - The complaint alleges that the defendants made materially false and misleading statements and failed to disclose adverse facts about Picard Medical's business and operations [1] - It is claimed that the defendants orchestrated a pump-and-dump scheme, where the stock price was artificially inflated through a social media promotion scheme [1] - Reports indicate that impersonators posing as legitimate financial advisors promoted Picard Medical in online forums, leading to a buying frenzy among retail investors [1] Group 3: Company Overview - Picard Medical Inc. is involved in the design, manufacturing, production, supply, marketing, and sale of medical device products, with its flagship product being an artificial heart called "SynCardia TAH" [1] - The company is headquartered in Tucson, Arizona, and operates in the United States, Europe, and China [1]